Diazenes as modificators of drug-resistance in tumor cells.

Osmak, M; Bordukalo, T; Ristov, A A; Jernej, B; Kosmrlj, J; Polanc, S

Osmak, M; Bordukalo, T; Ristov, A A; Jernej, B; Kosmrlj, J; Polanc, S.

Affiliation

Osmak M; Department of Molecular Genetics, Ruder Boskovic Institute, Zagreb, Croatia. osmak@rudjer.irb.hr

Neoplasma ; 47(6): 390-5, 2000.

Article in En | MEDLINE | ID: mdl-11263864

Subject(s)

Drug Resistance, Neoplasm; Imides/therapeutic use; Antineoplastic Agents/pharmacology; Antineoplastic Agents, Phytogenic/pharmacology; Cisplatin/pharmacology; Coloring Agents/pharmacology; Dose-Response Relationship, Drug; Doxorubicin/pharmacology; Glutathione/biosynthesis; HeLa Cells; Humans; Models, Chemical; Spectrophotometry; Tetrazolium Salts/pharmacology; Thiazoles/pharmacology; Tumor Cells, Cultured; Vincristine/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Drug Resistance, Neoplasm / Imides Limits: Humans Language: En Journal: Neoplasma Year: 2000 Document type: Article Affiliation country: Croatia Country of publication: Slovakia

Search on Google

Add to My VHL

XML

PubMed Links